Development of potent pan-coronavirus fusion inhibitors with a new design strategy.
Zhu Y, Gao Z, Feng X, Cheng L, Liu N, Liu C, Han S, Yang Q, Zou Q, Chong H, Zhang Z, Li M, Song G, He Y.
Zhu Y, et al. Among authors: yang q.
MedComm (2020). 2024 Jul 28;5(8):e666. doi: 10.1002/mco2.666. eCollection 2024 Aug.
MedComm (2020). 2024.
PMID: 39070180
Free PMC article.